Lord, Abbett & Co
KMTS

Lord, Abbett & Co’s Kestra Medical Technologies KMTS Stock Holding History

Lord, Abbett & Co’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-192,622
Closed -$5.11M – 638
2025
Q4 		$5.11M Sell
192,622
-66,474
-26% -$1.71M 0.02% 464
2025
Q3 		$6.16M Sell
259,096
-39,531
-13% -$707K 0.02% 442
2025
Q2 		$4.95M Buy
+298,627
New +$6.52M 0.02% 458

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co's KMTS Position: Q1 2026 in Review

Lord, Abbett & Co sold out of Kestra Medical Technologies (KMTS) in Q1 2026, closing a stake of 192,622 shares — an estimated $5.11M sold.

Lord, Abbett & Co first reported a position in KMTS in Q2 2025 and held it in 3 quarters. The position peaked at $6.16M in Q3 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Lord, Abbett & Co reported no remaining Kestra Medical Technologies position as of Q1 2026 after selling out during the quarter.
  • Lord, Abbett & Co sold 192,622 Kestra Medical Technologies shares in Q1 2026, an estimated $5.11M.
  • Lord, Abbett & Co first reported a position in Kestra Medical Technologies in Q2 2025 and held it in 3 quarters.
  • Lord, Abbett & Co's Kestra Medical Technologies position peaked at $6.16M in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.